RNDr. Ludmila Šebejová, Ph.D.
Head, Biobank and CELSPAC Laboratories
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. D29/1S118
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7637 |
---|---|
E‑mail: |
Total number of publications: 76
2009
-
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.
Blood, year: 2009, volume: 114, edition: 26, DOI
-
Monoclonal antibody rituximab sensitizes a proportion of CLL samples to fludarabine - searching for responsible genes
Year: 2009, type: Conference abstract
-
p53 inactivation and genomic abberations in chronic myeloid leukemia
Year: 2009, type: Conference abstract
-
Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine
European Journal of Haematology, year: 2009, volume: 82, edition: 2, DOI
-
Sensitization of leukemic cells to fludarabine by monoclonal antibody rituximab - identification of responsible genes
Year: 2009, type: Conference abstract
-
Senzitivizace CLL buněk na fludarabin monoklonální protilátkou rituximab - identifikace zodpovědných genů
Year: 2009, type: Conference abstract
2008
-
Abnormality v genech TP53 a ATM determinují odpověď CLL buněk na moderní léčbu
Year: 2008, type: Conference abstract
-
Heterozygotní delece ATM nezvyšuje rezistenci CLL buněk na fludarabin
Year: 2008, type: Conference abstract
-
Presence of heterozygous ATM deletion may not be critical for the response of CLL cells to fludarabine
Year: 2008, type: Conference abstract
-
Přítomnost heterozygotní delece ATM nedeterminuje odpověď CLL buněk na fludarabin
Year: 2008, type: Conference abstract